FDA Approves Xacduro

FDA Approves Xacduro (sulbactam and durlobactam) for the Treatment of Serious Infections Caused by Acinetobacter WALTHAM, Mass.–(BUSINESS WIRE)–May 23, 2023–

FDA Approves Syfovre

FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of Geographic Atrophy, a Leading Cause of Blindness WALTHAM, Mass., Feb. 17,

FDA Approves Twyneo

FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris NESS ZIONA, Israel, July 27, 2021 (GLOBE